Ravicti Interactions
There are 263 drugs known to interact with Ravicti (glycerol phenylbutyrate), along with 4 disease interactions. Of the total drug interactions, 5 are major, 249 are moderate, and 9 are minor.
- View all 263 medications that may interact with Ravicti
- View Ravicti disease interactions (4)
Most frequently checked interactions
View interaction reports for Ravicti (glycerol phenylbutyrate) and the medicines listed below.
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Avastin (bevacizumab)
- Baraclude (entecavir)
- Blincyto (blinatumomab)
- Corlanor (ivabradine)
- Cosentyx (secukinumab)
- Enbrel (etanercept)
- Entyvio (vedolizumab)
- Esbriet (pirfenidone)
- Hemlibra (emicizumab)
- Imbruvica (ibrutinib)
- Isentress (raltegravir)
- Kalydeco (ivacaftor)
- Keppra (levetiracetam)
- Matulane (procarbazine)
- Norvir (ritonavir)
- Ofev (nintedanib)
- Oncovin (vincristine)
- Pomalyst (pomalidomide)
- prednisone
- Pulmozyme (dornase alfa)
- Repatha (evolocumab)
- Revlimid (lenalidomide)
- Soliris (eculizumab)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tecentriq (atezolizumab)
- Trizivir (abacavir / lamivudine / zidovudine)
- Votrient (pazopanib)
Ravicti disease interactions
There are 4 disease interactions with Ravicti (glycerol phenylbutyrate) which include:
More about Ravicti (glycerol phenylbutyrate)
- Ravicti consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: urea cycle disorder agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.